Medisafe is the personalized medication management platform addressing all major causes of non-adherence. Medisafe’s cloud-based mobile platform personalizes content, resources and interventions — such as educational videos, coupons and motivational messages — based on each user's regimen, condition and specific circumstance. Medisafe fosters collaboration between patients, their loved ones and healthcare professionals through caregiver tools and reports, and helps the care continuum improve health outcomes and sustain quality care initiatives. Medisafe’s three and a half million patient and caregiver users who have recorded over 500 million successful medication doses on their iOS and Android smartphones and tablets and contributed 140,000 user reviews that average 4.5 out of 5 stars in the App Store and Google Play app stores.

Latest News Entry
Medisafe Demonstrates Double-Digit Impact on Medication Adherence in Hypertension Patients

Medisafe, the leading medication management platform released data showing that, on average, hypertensive patients increase their prescription refills by almost 10% after they start using the company's mobile app.

The IQVIA Institute for Human Data Science's Latest Report Names Medisafe as The Top Free & Publicly Available App for Medication Management

Designation Champions Medisafe's Medication Management Platform as A Best-in Class Solution for Managing the Critical Problem of Patient Non-adherence

Pogue's quest for the best pill-reminder app

I’ll admit it: Apps that remind you to take your pills are not as sexy as, say, folding laptops or MP3 toothbrushes. But they’re important. Every year an estimated 125,000 Americans die from taking their pills incorrectly, according to a 2012 study from the Annals of Internal Medicine.

Medisafe Raises $14.5M in Funding to Support Rapid Growth and Global Expansion

LONDON and BOSTON, March 1, 2017 — Medisafe®, the leading personalized medication management platform with over three and a half million patient and caregiver registered users, announced today that it has raised a $14.5M Series B funding round led by Octopus Ventures, and joined by M Ventures, to support the company’s rapid growth and global expansion. Other investors participating from previous rounds include Pitango Venture Capital, 7wire ventures, lool Ventures, TriVentures and Qualcomm Ventures.

all related news
all portfolio news